학술논문
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
Document Type
Article
Author
Source
In: BMJ Open . (BMJ Open, 31 January 2023, 13(1))
Subject
Language
English
ISSN
20446055